DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Rea D, Legros L, Raffoux E. et al. Intergroupe Français des Leucémies Myéloïdes Chronique; Group for Research in Adult Acute Lymphoblastic Leukemia.
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.

Leukemia 2006;
20 (03) 400-403

Download Bibliographical Data

Access:
Access: